Inventor · disambiguated record
Minmin Qin
Also filed as: QIN MINMIN
9 granted patents·8 pending applications·210 citations·filing 2000–2017
90Inventor score
Top patents by PatentIndex Score
17 records- 0197US7678890B2Compositions and methods of treating disease with FGFR fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2006·Granted Mar 16, 2010·67 cites·3 claims
- 0294US8580936B2Polynucleotides encoding FGFR1-IIIc ECD fusion proteinsWILLIAMS LEWIS T·Filed 2011·Granted Nov 12, 2013·40 cites·25 claims
- 0393US8173134B2ECD carboxy-terminal deletion FGFR4 fusion proteins and methods of producing themBOSCH ELIZABETH·Filed 2011·Granted May 8, 2012·24 cites·23 claims
- 0491US6569661B1Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereofBIOMARIN PHARM INC·Filed 2000·Granted May 27, 2003·63 cites·10 claims
- 0585US8501191B2FGFR2-IIIb fusion proteins and methods of making themBOSCH ELIZABETH·Filed 2012·Granted Aug 6, 2013·6 cites·18 claims
- 0677US6972124B2Precursor of N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzymeBIOMARIN PHARM INC·Filed 2003·Granted Dec 6, 2005·8 cites·5 claims
- 0766US9192683B2Methods of treating disease with FGFR1 fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2013·Granted Nov 24, 2015·0 cites·21 claims
- 0865US9173957B2FGFR2 fusion proteins comprising C-terminal deletion mutants of FGFR2-IIICFIVE PRIME THERAPEUTICS INC·Filed 2013·Granted Nov 3, 2015·0 cites·6 claims
- 0964US2017349643A1Compositions and methods of treating disease with fgfr fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1063US6866844B2Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzymeBIOMARIN PHARM INC·Filed 2002·Granted Mar 15, 2005·2 cites·47 claims
- 1159US2016096876A1Compositions and methods of treating disease with fgfr fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1259US2005287133A1Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzymeBIOMARIN PHARM INC·Filed 2005·Application pending·0 cites
- 1351US2008260715A1Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzymeBIOMARIN PHARM INC·Filed 2007·Application pending·0 cites
- 1446US2006040348A1Methods for producing and purifying recombinant alpha-L-iduronidaseQIN MINMIN·Filed 2003·Application pending·0 cites
- 1543US2002146802A1Methods for producing and purifying recombinant alpha-L-iduronidaseFiled 2001·Application pending·0 cites
- 1642US2011319324A1Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseasesLIN JUNYU·Filed 2010·Application pending·0 cites
- 1742US2007054851A1Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseasesLIN JUNYU·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Minmin Qin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →